about
The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorderModeling the development of panic disorder with interoceptive conditioning.The role of "interoceptive" fear conditioning in the development of panic disorder.Reduced autobiographical memory specificity is associated with impaired discrimination learning in anxiety disorder patients.The anatomy of fear learning in the cerebellum: A systematic meta-analysis.Carbon dioxide inhalation induces dose-dependent and age-related negative affectivityFrontal EEG asymmetry during symptom provocation predicts subjective responses to intrusions in survivors with and without PTSD.Cigarette smoking and panic: a critical review of the literature.Endogenous opioid release in the human brain reward system induced by acute amphetamine administration.Alcohol use disorders and panic disorder: a review of the evidence of a direct relationship.The weight of cognitions in panic: the link between misinterpretations and panic attacks.Unraveling the relationship between trait negative affectivity and habitual symptom reportingEffects of tryptophan depletion and tryptophan loading on the affective response to high-dose CO2 challenge in healthy volunteersExperience sampling-based personalized feedback and positive affect: a randomized controlled trial in depressed patients.Neural correlates of reward processing in adults with 22q11 deletion syndrome.Biological challenge procedures used to study co-occurring nicotine dependence and panic disorder.Brain and Behavior Changes following Exposure Therapy Predict Outcome at 8-Year Follow-Up.Can formulation affect tryptophan depletion results? Hints from studies in experimental panic.Novel investigational therapeutics for panic disorder.Defensive activation to (un)predictable interoceptive threat: The NPU respiratory threat test (NPUr).Pharmacokinetic Drug-Drug Interactions of Mood Stabilizers and Risperidone in Patients Under Combined Treatment.Carbon dioxide inhalation as a human experimental model of panic: the relationship between emotions and cardiovascular physiology.Pharmacokinetic patterns of risperidone-associated adverse drug reactions.Risperidone-induced extrapyramidal side effects: is the need for anticholinergics the consequence of high plasma concentrations?A therapeutic application of the experience sampling method in the treatment of depression: a randomized controlled trial.Erratum to: Neural correlates of reward processing in adults with 22q11 deletion syndrome.Effect of buspirone on the behavioral regulation of rats in low versus high anxiety conditions.Nonhomogeneous results in place learning among panic disorder patients with agoraphobia.Attenuation of fear-like response by escitalopram treatment after electrical stimulation of the midbrain dorsolateral periaqueductal gray.Increased plasma corticosterone levels after periaqueductal gray stimulation-induced escape reaction or panic attacks in rats.L-5-hydroxytryptophan induced increase in salivary cortisol in panic disorder patients and healthy volunteers.Acute L-5-hydroxytryptophan administration inhibits carbon dioxide-induced panic in panic disorder patients.Sleep complaints in panic disorder patients.Hypothalamic-pituitary-adrenal axis function following a 35% CO2 inhalation in healthy volunteers.Cigarette smoking and 35% CO(2) induced panic in panic disorder patients.Negative affectivity in smokers applying to smoking cessation clinics: a case-control study.CO2 challenge results in hypothalamic-pituitary-adrenal activation in healthy volunteers.Behavioral pattern separation and its link to the neural mechanisms of fear generalization.A Clinically-Translatable Machine Learning Algorithm for the Prediction of Alzheimer's Disease Conversion in Individuals with Mild and Premild Cognitive Impairment.Chronic obsessive-compulsive disorder: prognostic factors.
P50
Q28296985-0D590147-96DF-48C6-A861-BB2AF4679836Q30151578-7ABDA595-44E4-4DDB-8C81-93335AE3E18AQ30224755-3075EF8C-15D0-418E-8DDE-E71E59A75212Q30656218-543D8CF7-F3C7-4CFA-AD0C-AF795CFF1824Q31002078-EE709D5C-E449-4034-8F5C-C853C7BDE5ADQ33301340-D3F1CDA7-C3A6-4556-991C-DAED1FFB78EDQ33453432-71079DAD-0269-4497-93FC-7BFFC4B783A9Q34020422-0CB4C52D-25B0-4E52-A6F7-B9DE0A751B71Q34258315-42E276A2-A292-447D-B5FD-4693D0C19A88Q34641896-7F253E31-4753-46B9-86E9-C0661B451BB8Q34934939-1A6006FD-3FDE-4562-8FA3-A1A6F3E23CBCQ34989241-C1F03814-3C1D-4616-878B-FDE1840F9822Q35007729-476D413A-69C3-4432-9327-958F1E58EDF5Q35649611-66BFF720-647F-4A61-8CAB-5B157FC49BCEQ37096980-52230A37-1B5B-469B-AC81-E98F68F86377Q37133516-F32757E8-E771-465C-A2EC-95601E3D932CQ37630753-7CA26467-1461-4184-9481-EDB4DDE2E80AQ38178790-B4A9077D-A395-4E30-9E48-537D9999E2C9Q38300166-64D86244-6F75-4AF3-915D-55133C3DC3D3Q38907943-F2F14497-CEDB-4627-A190-AD81CBE95D20Q39217906-1153CD9C-4433-4E48-B284-88AFCC7E855EQ39392889-91D60C6C-5D7A-46B8-B04A-9306808AFAAAQ39633628-727BFE1C-29A2-46A1-AF20-A541DC24F37EQ39775312-FDE5B77F-AE1E-4EAA-869C-CE9E1C1CD02FQ41933596-45416879-C8C7-44BE-87F2-F77908724603Q42381065-47CDF5D5-C705-464A-9A4F-965B6BCEF1F4Q42664095-F6927DA4-A6AD-4A83-94B8-96E2B94A9697Q42664975-33A1CF38-3308-4340-8D15-2AB1DE5C6F38Q42675038-892EEFC5-E0B0-49C9-993E-AE9A2C7660A8Q42684408-DD85B1DD-DDD3-442D-95BD-9F8D2F052703Q44034079-3E2CDCB5-E6E8-49B6-A410-F8FE643BEDFEQ44297596-8A5FEFE2-E639-4D34-9C80-14CBF4E08FE9Q44351964-EEF54E82-BC14-4509-BEB9-69FF38694D06Q44748269-1D751C09-578C-4BEF-A8BE-D1938D4EB6A3Q45034701-D3A9CA41-20E0-42FD-B562-2D47F6D89E12Q46185197-1B55B866-E455-4737-B392-C99BB5D45B26Q46486022-DA9D25BF-53DA-4970-AB6A-E30408C02AB4Q47112223-834D0C97-23CF-48A7-86F5-BFDD7B2522A4Q47553444-E5059915-CAB5-4326-B2C1-98A62183F30BQ47558039-CE367341-2C42-4014-8EA0-5A384CC19B91
P50
name
Koen Schruers
@ast
Koen Schruers
@en
Koen Schruers
@es
Koen Schruers
@nl
type
label
Koen Schruers
@ast
Koen Schruers
@en
Koen Schruers
@es
Koen Schruers
@nl
altLabel
K.R.J. Schruers
@en
K.R.J. Schruers
@nl
Koen R J Schruers
@en
prefLabel
Koen Schruers
@ast
Koen Schruers
@en
Koen Schruers
@es
Koen Schruers
@nl
P106
P19
P21
P31
P569
1966-01-01T00:00:00Z